Trial
NCT05356858
An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Xuanwu Hospital, Beijing
Collaborators
—
Condition
Neuromyelitis Optica
Intervention
zanubrutinib
Why stopped
Difficult in participant recruiting
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-27